In Hae Park

7PUBLICATIONS
29CO-AUTHORS
Natural language processingMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2026
Can Small Open-Source Language Models With Retrieval-Augmented Generation Match GPT-4 Performance in Breast Cancer Clinical Decision Support?

|Nov 22, 2023
A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.

David W Cescon, John Hilton, Serafin Morales Murilo

|Mar 09, 2021
Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2- advanced breast cancer: MONARCH 2 & 3 trials.

Masakazu Toi, Kenichi Inoue, Norikazu Masuda

|Nov 10, 2019
Genomic Characteristics of Triple-Negative Breast Cancer Nominate Molecular Subtypes That Predict Chemotherapy Response.

Jihyun Kim, Doyeong Yu, Youngmee Kwon

|Sep 19, 2019
Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer.

In Hae Park, Han Na Yang, Su Yeon Jeon

|Nov 20, 2018
Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database.

Young Ae Kim, Hyunsoon Cho, Nayoung Lee

Pageof 2

Frequent Collaborators

3 joint publications

Keun Seok Lee

3 joint publications

Eun Sook Lee

2 joint publications

Sun-Young Kong

1 joint publications

Hak Jin Kim